189 related articles for article (PubMed ID: 18041918)
1. Lentiviral vector-mediated RNAi and its use for cancer research.
Sumimoto H; Kawakami Y
Future Oncol; 2007 Dec; 3(6):655-64. PubMed ID: 18041918
[TBL] [Abstract][Full Text] [Related]
2. The RNA silencing technology applied by lentiviral vectors in oncology.
Sumimoto H; Kawakami Y
Methods Mol Biol; 2010; 614():187-99. PubMed ID: 20225045
[TBL] [Abstract][Full Text] [Related]
3. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
4. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
Liu YP; Westerink JT; ter Brake O; Berkhout B
Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
[TBL] [Abstract][Full Text] [Related]
5. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
6. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
7. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
[TBL] [Abstract][Full Text] [Related]
8. Control of HIV-1 replication by RNA interference.
Lee NS; Rossi JJ
Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
11. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference.
Westerhout EM; ter Brake O; Berkhout B
Retrovirology; 2006 Sep; 3():57. PubMed ID: 16948865
[TBL] [Abstract][Full Text] [Related]
12. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL; Chang WT
Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
[TBL] [Abstract][Full Text] [Related]
13. Gene silencing of HIV-1 by RNA interference.
Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):57-65. PubMed ID: 15185724
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.
Guo H; Zhang J; Inal C; Nguyen T; Fruehauf JH; Keates AC; Li CJ
Gene Ther; 2011 Jan; 18(1):95-105. PubMed ID: 20811467
[TBL] [Abstract][Full Text] [Related]
16. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
17. An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors.
Motegi Y; Katayama K; Sakurai F; Kato T; Yamaguchi T; Matsui H; Takahashi M; Kawabata K; Mizuguchi H
J Control Release; 2011 Jul; 153(2):149-53. PubMed ID: 21515317
[TBL] [Abstract][Full Text] [Related]
18. Generation of genetic constructs that simultaneously express several shRNAs.
Kretova OV; Alembekov IR; Tchurikov NA
Biotechniques; 2012 May; 52(5):. PubMed ID: 26307255
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
Gu W; Payne E; Sun S; Burgess M; McMillan NA
Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
Morris KV; Rossi JJ
Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
